Modified-release nifedipine: a review of the use of modified-release formulations in the treatment of hypertension and angina pectoris (Q34566315)

3 August 2017

1 reference

title

Modified-release nifedipine: a review of the use of modified-release formulations in the treatment of hypertension and angina pectoris (English)

1 reference

3 August 2017

1 reference

Katherine F Croom

1 reference

3 August 2017

Keri Wellington

series ordinal

1 reference

3 August 2017

publication date

1 January 2006

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

page(s)

497-528

1 reference

Arterial hemodynamics in human hypertension. Effects of the calcium channel antagonist nifedipine.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666040-00007

Differential effects of nifedipine and co-amilozide on the progression of early carotid wall changes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666040-00007

Nifedipine and mortality. Grave defects in the dossier

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666040-00007

Significant food interactions observed with a nifedipine modified-release formulation marketed in the European Union.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666040-00007

Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666040-00007

Efficacy, tolerability and influence on "quality of life" of nifedipine GITS versus amlodipine in elderly patients with mild-moderate hypertension

21 January 2018

1 reference

12 December 2020

Differential effects of lercanidipine and nifedipine GITS on plasma norepinephrine in chronic treatment of hypertension

1 reference

12 December 2020

Formulation dependent pharmacokinetics--does the dosage form matter for nifedipine?

1 reference

12 December 2020

The Risk of Myocardial Infarction Associated With Antihypertensive Drug Therapies

1 reference

12 December 2020

Nifedipine retard was as effective as angiotensin converting enzyme inhibitors in preventing cardiac events in high-risk hypertensive patients with diabetes and coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases

1 reference

12 December 2020

Differential activation of cardiac and peripheral sympathetic nervous system by nifedipine: role of pharmacokinetics

1 reference

12 December 2020

Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders

1 reference

12 December 2020

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

12 December 2020

Hotline sessions of the 26th European Congress of Cardiology

1 reference

12 December 2020

Effects of nifedipine GITS 20 mg or enalapril 20 mg on blood pressure and inflammatory markers in patients with mild-moderate hypertension

1 reference

12 December 2020

Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study e

1 reference

12 December 2020

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

12 December 2020

Efficacy of a low dose nifedipine GITS (20 mg) in patients with mild to moderate hypertension

1 reference

12 December 2020

Effect of Calcium Antagonists on Plasma Norepinephrine Levels, Heart Rate, and Blood Pressure

1 reference

12 December 2020

Shanghai trial of nifedipine in the elderly (STONE)

1 reference

12 December 2020

Dihydropyridine calcium channel blockers: basic pharmacological similarities but fundamental therapeutic differences

1 reference

12 December 2020

Comparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) randomized trial

1 reference

12 December 2020

The influence of two types of meal on the pharmacokinetics of a modified-release formulation of nifedipine (Adalat Retard)

1 reference

12 December 2020

Comparison of the efficacy of dihydropyridine calcium channel blockers in African American patients with hypertension. ISHIB Investigators Group. International Society on Hypertension in Blacks

1 reference

12 December 2020

The efficacy and safety of once-daily nifedipine coat-core in the treatment of mild-to-moderate hypertension. Adalat CC Cooperative Study Group

1 reference

12 December 2020

Clinical significance of renal function in hypertensive patients at high risk: results from the INSIGHT trial

1 reference

12 December 2020

Comparison of two calcium blockers on hemodynamics, left ventricular mass, and coronary vasodilatory in advanced hypertension

1 reference

12 December 2020

Effects of the combination of low-dose nifedipine GITS 20 mg and losartan 50 mg in patients with mild to moderate hypertension

1 reference

12 December 2020

Quantitative coronary angiogram analysis: nifedipine retard versus angiotensin-converting enzyme inhibitors (JMIC-B side arm study).

1 reference

12 December 2020

Outcomes with nifedipine GITS or Co-amilozide in hypertensive diabetics and nondiabetics in Intervention as a Goal in Hypertension (INSIGHT).

1 reference

12 December 2020

Comparative effects of lercanidipine, lacidipine, and nifedipine gastrointestinal therapeutic system on blood pressure and heart rate in elderly hypertensive patients: the ELderly and LErcanidipine (ELLE) study

1 reference

12 December 2020

Are calcium antagonists beneficial in diabetic patients with hypertension?

1 reference

12 December 2020

Comparative study of lacidipine and nifedipine SR in the treatment of hypertension: an Italian multicenter study. The Northern Italian Study Group of Lacidipine in Hypertension

1 reference

12 December 2020

Nifedipine gastrointestinal therapeutic system (GITS) for hypertensive patients in a primary care setting: results of the Extended Release Adalat Canadian Trial (EXACT)

1 reference

12 December 2020

Regression of cardiac hypertrophy by 1,4 dihydropyridines in hypertensive patients

1 reference

12 December 2020

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

1 reference

12 December 2020

Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the International Multicenter Angina Exercise (IMAGE) Study.

1 reference

12 December 2020

Angiotensin-converting-enzyme inhibition in stable coronary artery disease

1 reference

12 December 2020

Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators

1 reference

12 December 2020

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

12 December 2020

Improvement of insulin sensitivity by a long-acting nifedipine preparation (nifedipine-CR) in patients with essential hypertension

1 reference

12 December 2020

Calcium channel blocker nifedipine slows down progression of coronary calcification in hypertensive patients compared with diuretics

1 reference

12 December 2020

Nifedipine and atenolol singly and combined for treatment of essential hypertension: comparative multicentre study in general practice in the United Kingdom. Nifedipine-Atenolol Study Review Committee

1 reference

12 December 2020

Diagnostic and prognostic value of coronary artery calcium screening

1 reference

12 December 2020

Structure and function of resistance arteries of hypertensive patients treated with a beta-blocker or a calcium channel antagonist

1 reference

12 December 2020

Formulation-dependent food effects demonstrated for nifedipine modified-release preparations marketed in the European Union

1 reference

12 December 2020

Rate of increase in the plasma concentration of nifedipine as a major determinant of its hemodynamic effects in humans

1 reference

12 December 2020

Relation of regression of left ventricular hypertrophy to changes in ambulatory blood pressure after long-term therapy with perindopril versus nifedipine

1 reference

12 December 2020

Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system. A controlled-release formulation of nifedipine

1 reference

12 December 2020

A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily, and isosorbide dinitrate twice daily in patients with chronic stable angina

1 reference

12 December 2020

Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized,

1 reference

12 December 2020

Long-term comparison between captopril and nifedipine in the progression of renal insufficiency

1 reference

12 December 2020

Evaluation of changes in sympathetic nerve activity and heart rate in essential hypertensive patients induced by amlodipine and nifedipine

1 reference

12 December 2020

Long‐Term Survival and Use of Antihypertensive Medications in Older Persons

1 reference

12 December 2020

Nifedipine GITS versus diltiazem in chronic stable angina: a randomised multicentre study

1 reference

12 December 2020

Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS

1 reference

12 December 2020

Nifedipine and enalapril equally reduce the progression of nephropathy in hypertensive type 2 diabetics

1 reference

12 December 2020

Safety and Efficacy of Once-Daily Captopril Plus Hydrochlorothiazide versus Nifedipine Gastrointestinal Therapeutic System in Black Patients with Mild to Moderate Hypertension

1 reference

12 December 2020

Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis

1 reference

12 December 2020

Effects of nifedipine GITS and diuretics in isolated systolic hypertension--a subanalysis of the INSIGHT study

1 reference

12 December 2020

Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial

1 reference

12 December 2020

Effect of nifedipine and cerivastatin on coronary endothelial function in patients with coronary artery disease: the ENCORE I Study (Evaluation of Nifedipine and Cerivastatin On Recovery of coronary Endothelial function).

1 reference

12 December 2020

Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk

1 reference

12 December 2020

Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: a prospective randomized double-blind study

1 reference

12 December 2020

Effects of nifedipine treatment on the renin-angiotensin-aldosterone axis

1 reference

12 December 2020

The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties

1 reference

12 December 2020

Effects of antihypertensive drugs on endothelial dysfunction: clinical implications

1 reference

12 December 2020

Effectiveness of nifedipine GITS in combination with atenolol in chronic stable angina.

1 reference

12 December 2020

Efficacy and safety of carvedilol in comparison with nifedipine sustained-release in chronic stable angina

1 reference

12 December 2020

Comparison of the efficacy and safety of nifedipine coat-core versus amlodipine in the treatment of patients with mild-to-moderate essential hypertension. Hypertension Study Group

1 reference

12 December 2020

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

1 reference

12 December 2020

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

1 reference

12 December 2020

Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product

1 reference

12 December 2020

Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. The TIBET Study Group

1 reference

12 December 2020

Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial

1 reference

12 December 2020

Controlled-release nifedipine and candesartan low-dose combination therapy in patients with essential hypertension: the NICE Combi (Nifedipine and Candesartan Combination) Study

1 reference

12 December 2020

Randomized double-blind comparison of isosorbide dinitrate and nifedipine in variant angina pectoris

1 reference

12 December 2020

Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine

1 reference

12 December 2020

Twenty-four hour ambulatory blood pressure in the International Nifedipine GITS Study Intervention as a Goal in Hypertension Treatment (INSIGHT).

1 reference

12 December 2020

Effects of amlodipine and nifedipine retard on autonomic nerve activity in hypertensive patients

1 reference

12 December 2020

Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial

1 reference

12 December 2020

Nifedipine gastrointestinal therapeutic system (GITS). A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in hypertension and angina pectoris

1 reference

12 December 2020

Effect of lacidipine and nifedipine GITS on platelet function in patients with essential hypertension

1 reference

12 December 2020

The effect of food on the pharmacokinetics of nifedipine in two slow release formulations: pronounced lag-time after a high fat breakfast

1 reference

12 December 2020

Nifedipine gastrointestinal therapeutic system in the treatment of hypertension. Results of a multicenter trial. The Modern Approach to the Treatment of Hypertension (MATH) Study Group.

1 reference

12 December 2020

Nifedipine gastrointestinal therapeutic system versus atenolol in stable angina pectoris. The Netherlands Working Group on Cardiovascular Research (WCN)

1 reference

12 December 2020

Comparison of nifedipine and propranolol used in combination with diuretics for the treatment of hypertension

1 reference

12 December 2020

Nifedipine. Dose-related increase in mortality in patients with coronary heart disease

1 reference

12 December 2020

Nebivolol versus nifedipine in the treatment of essential hypertension: a double-blind, randomized, comparative trial

1 reference

12 December 2020

Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders

1 reference

12 December 2020

The role of existing and newer calcium channel blockers in the treatment of hypertension

1 reference

12 December 2020

Differential effects of once-daily antihypertensive drugs on blood pressure, left ventricular mass and sympathetic activity: Nifedipine-GITS versus felodipine-ER versus enalapril.

1 reference

12 December 2020

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

1 reference

12 December 2020

A study of losartan, alone or with hydrochlorothiazide vs nifedipine GITS in elderly patients with diastolic hypertension

1 reference

12 December 2020

Lisinopril versus slow-release nifedipine in the treatment of mild to moderate hypertension: a multicentre study. The Cooperative Study Group

1 reference

12 December 2020

1 reference

12 December 2020

Reduction of cardiovascular structural changes by nifedipine GITS in essential hypertensive patients

1 reference

12 December 2020

Efficacy, tolerability, and quality of life of losartan, alone or with hydrochlorothiazide, versus nifedipine GITS in patients with essential hypertension.

1 reference

12 December 2020

Effects of long-acting calcium channel antagonists on neurohumoral factors: comparison of nifedipine coat-core with amlodipine.

1 reference

12 December 2020

Hypertension and non-insulin-dependent diabetes. A comparison between an angiotensin-converting enzyme inhibitor and a calcium antagonist

1 reference

12 December 2020

Persistence with antihypertensives related to formulation: the case of nifedipine

1 reference

12 December 2020

Comparison of once-daily nifedipine controlled-release with twice-daily nifedipine retard in the treatment of essential hypertension

1 reference

12 December 2020

The safety and efficacy of once-daily nifedipine coat-core in combination with atenolol in hypertensive patients. Adalat CC Cooperative Study Group

1 reference

12 December 2020

Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial

1 reference

12 December 2020

A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease

1 reference

12 December 2020

2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension

1 reference

12 December 2020

Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients

1 reference

12 December 2020

Effectiveness of once-daily monotherapy with a new nifedipine sustained release calcium antagonist

1 reference

12 December 2020

10.2165/00003495-200666040-00007

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

1028243040

0 references

1 reference